Stockreport

Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies [Yahoo! Finance]

Quoin Pharmaceuticals, Ltd. - American Depositary Shares  (QNRX) 
PDF eligible subjects, potentially expedite recruitment and lead to a more robust data set This important development represents the first ever inclusion of non-adult subj [Read more]